市场调查报告书
商品编码
1284263
2028 年医药过滤市场预测——按产品、技术、类型、应用和地区分列的全球分析Pharmaceutical Filtration Market Forecasts to 2028 - Global Analysis By Product, Technique, Type, Application and By Geography |
根据 Stratistics MRC 的数据,2022 年全球製药过滤市场规模将达到 223 亿美元,预计到 2028 年将达到 451 亿美元,预测期内復合年增长率为 12.4%。成长于
製药过滤是一种分离程序,其中处理过的材料通过过滤膜以从中提取不需要的颗粒。 这种过滤技术有助于从介质和溶液中去除空气中的颗粒。 此外,还使用过滤器从固体、空气、液体和气体中去除颗粒物和细菌等污染物。 製药过滤技术还常用于其他几个领域,包括最终产品加工、水净化、原料过滤、细胞分离和空气净化。
根据 Evaluate Pharma 的数据,2014 年全球医药研发支出价值 1440 亿美元,预计到 2028 年这一数字将达到 2850 亿美元。
为确保最终产品的完整性和质量,製药公司必须保持高清洁度标准。 在製造过程中,依赖过滤系统从液体和气体中去除污染物和杂质。 对高质量药品不断增长的需求以及满足监管要求的需求预计将推动市场增长。
製造过滤设备或系统需要大量的前期资金。 其他因素如劳动力成本和专业知识也包含在製造成本中。 大型切向流过滤系统很昂贵,但安装整个製造综合体的上游和下游成本更高。 资本密集型市场特征会阻碍市场扩张。
仿製药开发的研发活动不断增加,以及对单克隆抗体、治疗性蛋白质和疫苗等各种医疗保健疗法的研究,为市场带来了增长机会。 增加政府支出以支持研发活动预计也将推动市场增长。
药品和生物製药的製造受到严格监管。 在许多国家/地区,製造过程每个阶段的药品卫生和质量都受到严格的监管。 因此,在传统机器上製造药品和生物製药非常昂贵且困难。 製药过滤市场的发展受到製药行业严格监管的阻碍。
使用更复杂类型的製药过滤设备是 COVID-19 更加重视製药行业的安全标准和质量的结果。 一次性过滤技术还可以防止交叉污染,因此大流行促进了其在製药行业的使用,重振了製药过滤市场。 在大流行封锁期间,全球大多数药用过滤器製造商都已停止生产其产品。
膜过滤器具有精确且均匀的孔径分布,可确保始终如一的过滤质量,这有望在该领域带来有利可图的增长。 膜过滤器也可以由多种材料製成,使其适用于製药应用。 此外,膜过滤器符合製药生产指南。
微滤部分由于其多功能性和从生物製药中去除各种杂质的综合能力,预计在预测期内将以最快的复合年增长率增长。 此外,这种方法可以过滤掉颗粒和污染物,而不会对介质稳定性或生物活性产生不利影响。 此外,微滤系统製造商正在采取战略行动来支持市场。
由于对製药过滤产品的需求激增以及对製药和生物製药行业的投资增加,预计亚太地区在预测期内将占据最大的市场份额。 此外,研发部门的发展、医改的进步、医疗基础设施的完善、疾病的传播、医疗行业的技术发展,都在促进市场的扩大。
由于采用了创新的新技术,预计欧洲在预测期内的复合年增长率最高。 此外,由于对生物製药的需求不断增长和医疗保健行业的发展,市场正在扩大。 此外,该地区强大的分销网络支持製药过滤行业在该地区的扩张和发展。
2023 年 1 月,Sartorius AG(德国)和 RoosterBio, Inc.(美国)达成合作协议,为基于外泌体的疗法提供纯化解决方案并建立可扩展的下游製造工艺。
2022 年 6 月,Donaldson Company Inc.(美国)收购了 Purilogics, LLC(美国),这是一家生产膜色谱产品的早期生物技术公司。 此次收购将使公司能够获得范围广泛的生物製剂纯化工具。
According to Stratistics MRC, the Global Pharmaceutical Filtration Market is accounted for $22.3 billion in 2022 and is expected to reach $45.1 billion by 2028 growing at a CAGR of 12.4% during the forecast period. Pharmaceutical filtration is a separation procedure in which processed materials are passed through a filtration membrane in order to extract undesirable particles from them. This filtration technique aids in removing suspended particles from a medium or solution. Additionally, pollutants like particle matter and bacteria are eliminated from solids, air, liquids, and gases using filters. The processing of final products, water purification, raw material filtration, cell separation, and air purification are a few other fields where pharmaceutical filtration techniques are commonly used.
According to Evaluate Pharma, worldwide pharmaceutical R&D spending was valued at USD 144 billion in 2014, and this figure is estimated to reach USD 285 billion by 2028.
To ensure the integrity and quality of the ultimate product, pharmaceutical businesses must maintain high cleanliness standards. The removal of pollutants and impurities from liquids and gases during production depends on the filtering systems. The rising demand for high-quality pharmaceutical products, as well as the need to meet regulatory requirements, is expected to drive market growth.
The production of filtering equipment or systems requires a significant upfront financial expenditure. The cost of labour and other components such as technical expertise go into total manufacturing expenses. Large tangential flow filtration systems are expensive, but it costs more to put up a whole manufacturing complex with both upstream and downstream operations. The market's capital-intensive nature could impede market expansion.
The increase in the number of research and development activities for developing generic pharmaceuticals and researching various healthcare therapies such as monoclonal antibodies, therapeutic proteins, and vaccines represents a growth opportunity for the market. The government increased spending to assist research and development activities is also projected to drive market growth.
Pharmaceutical and biopharmaceutical manufacturing is closely regulated. The sanitation and quality of medications at each stage of the manufacturing process are governed by tight rules in a number of nations. As a result, producing medicines and biopharmaceuticals with conventional machinery is very expensive and difficult. The development of the pharmaceutical filtration market is hampered by the stringent regulations in the pharmaceutical sector.
The usage of more sophisticated types of pharmaceutical filtration devices is a result of COVID-19's greater emphasis on safety standards and quality within the pharmaceutical business. Because single-use filtering technologies can prevent cross-contamination, the pandemic also saw an increase in their use in the pharmaceutical industry, which helped the market for pharmaceutical filtration. During the pandemic lockdown, the majority of pharmaceutical filter manufacturers in the world stopped producing their products.
The membrane filters segment is estimated to have a lucrative growth, due to the capability of membrane filters to have a precise and uniform pore size distribution ensuring a consistent filtration quality. Membrane filters can also be created from a variety of materials, making them adaptable for use in pharmaceutical applications. Membrane filters also follow the manufacturing guidelines for pharmaceutical businesses.
The microfiltration segment is anticipated to witness the fastest CAGR growth during the forecast period, due to its versatility and overall ability to remove a wide range of impurities from biopharmaceutical products. The method also filters out particles and contaminants without adversely affecting the medium's stability or biological activity. Additionally, producers of microfiltration systems are taking strategic actions that will support the market.
Asia Pacific is projected to hold the largest market share during the forecast period owing to surge in demand for pharmaceutical filtration products and rise in investments in the pharmaceutical and biopharmaceutical industry. In addition, the development of the R&D sector, the rise in healthcare reforms, improvements in healthcare infrastructure, rising disease prevalence, and technical developments in the healthcare industry all contribute to the market's expansion.
Europe is projected to have the highest CAGR over the forecast period, owing to the adoption of innovative and latest technologies. The market is also expanding as a result of the rising demand for biopharmaceuticals and the development of the healthcare industry. The expansion and development of the pharmaceutical filtration industry in the region is also being aided by the region's robust distribution network.
Some of the key players profiled in the Pharmaceutical Filtration Market include Meissner Filtration Products, Inc., Parker Hannifin Corp., Merck KGaA, 3M Company, Eaton Corporation PLC, Thermo Fisher Scientific Inc., Danaher, Amazon Filters Ltd., Graver Technologies, Sartorius AG., GE Healthcare, Pall Corporation, Donaldson Company, Inc., Repligen Corporation and Membrane Solutions.
In January 2023, Sartorius AG (Germany) and RoosterBio, Inc. (US) signed a collaboration deal to provide purification solutions and establish scalable downstream manufacturing processes for exosome-based therapies.
In June 2022, Donaldson Company Inc. (US) acquired Purilogics, LLC (US), an early-stage biotechnology company that manufactures membrane chromatography products. Through this acquisition, the company will have access to the purification tools for a wide range of biologics.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.